Use access key #2 to skip to page content.
$6.60 0.23 (3.58%)
10/10/2008 3:58 PM

Repros Therapeutics, Inc. (RPRX)

CAPS Rating:
*

A biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders.

View All Commentary (RPRX)

Recs

1

Avatar zzlangerhans (98.66) Submitted: 8/15/07 9:23 PM : Outperform Start Price: $12.68 RPRX Score: -11.27

Androxal and Proellex are likely 2008 NDA submissions. Coverage from unbiased sources is very thin, and there are potential problems with cytopathologic endometrial changes with Proellex. However, despite price near 13 market cap is only 165M which improves the risk/benefit profile substantially.

Report this Post Replies: 0 | Reply

Featured Broker Partners